If there is one thing income investors hate, it's when a company decides to slash or suspend its dividend. Yes, sometimes the business requires it, but that's cold comfort for those who count on regular and rising payouts. Recently, the leading pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) made the difficult decision to decrease its dividend by 48%, much to the dismay of investors.

The company's financial position arguably justifies the move, but what about investing in a stock whose underlying business is unlikely to make such a decision necessary? Here are two such stocks: Johnson Johnson (NYSE: JNJ) and Microsoft (NASDAQ: MSFT). 

Johnson Johnson has problems of its own. In 2022, the Inflation Reduction Act (IRA) was enacted into law in the U.S. Among other things, it will seek to make some drugs more affordable by allowing the government to negotiate better prices for them.

Continue reading

Source Fool.com